目目的的分析集中带量采购政策实施2年后北京市回民医院中成药在心血管疾病治疗中的使用变化,评估其对临床用药结构与药品费用的影响。方法采用回顾性研究方法,选取北京市回民医院2023年4月1日至2025年3月31日期间的中成药采购与使用数...目目的的分析集中带量采购政策实施2年后北京市回民医院中成药在心血管疾病治疗中的使用变化,评估其对临床用药结构与药品费用的影响。方法采用回顾性研究方法,选取北京市回民医院2023年4月1日至2025年3月31日期间的中成药采购与使用数据为研究对象,比较不同中成药的限定日剂量数(defined daily dose,DDD)、日均治疗费用(daily drug cost,DDC)及总费用的变化情况,分析集中带量采购政策的干预效果。结果实施集中带量采购2年后,大部分中成药DDD下降,少数口服药物(如心可舒类、复方血栓通)DDD上升;绝大多数药品DDC下降,其中冠心宁注射液与银杏达莫注射液降幅最大(均为20.00%);各药品实际费用普遍下降,灯盏生脉胶囊与复方丹参滴丸节省费用最多,分别为75.31万元和81.07万元。结论集中带量采购政策有效促进中成药使用结构调整和成本控制,显著提升药品使用的经济性与合理性。展开更多
Chinese medicinal materials are the material basis for the inheritance and development of traditional Chinese medicine.Intellectual property protection for the entire industrial chain of traditional Chinese medicinal ...Chinese medicinal materials are the material basis for the inheritance and development of traditional Chinese medicine.Intellectual property protection for the entire industrial chain of traditional Chinese medicinal materials promotes the inheritance and innovation of traditional Chinese medicine,and contributes to rural revitalization and the building of an agricultural power.This article provides an overview of the traditional Chinese medicinal materials in Hubei Province.It conducts a detailed investigation into the intellectual property resources of the province s traditional Chinese medicinal materials from aspects such as traditional knowledge,genetic resources,new plant varieties,patents,geographical indications,and trademarks.It analyzes the eight main problems in the protection,inheritance,and innovative development of intellectual property rights,and puts forward corresponding suggestions,such as establishing an intellectual property rights rule system for specific fields of traditional Chinese medicinal materials,promoting the"Famous Brand Action in Rural Areas",and building a"Hubei s Sixteen Superior Herbs"cluster of traditional Chinese medicinal materials.展开更多
文摘目目的的分析集中带量采购政策实施2年后北京市回民医院中成药在心血管疾病治疗中的使用变化,评估其对临床用药结构与药品费用的影响。方法采用回顾性研究方法,选取北京市回民医院2023年4月1日至2025年3月31日期间的中成药采购与使用数据为研究对象,比较不同中成药的限定日剂量数(defined daily dose,DDD)、日均治疗费用(daily drug cost,DDC)及总费用的变化情况,分析集中带量采购政策的干预效果。结果实施集中带量采购2年后,大部分中成药DDD下降,少数口服药物(如心可舒类、复方血栓通)DDD上升;绝大多数药品DDC下降,其中冠心宁注射液与银杏达莫注射液降幅最大(均为20.00%);各药品实际费用普遍下降,灯盏生脉胶囊与复方丹参滴丸节省费用最多,分别为75.31万元和81.07万元。结论集中带量采购政策有效促进中成药使用结构调整和成本控制,显著提升药品使用的经济性与合理性。
基金Supported by the Project of National Social Science Fund of China(22CMZ015).
文摘Chinese medicinal materials are the material basis for the inheritance and development of traditional Chinese medicine.Intellectual property protection for the entire industrial chain of traditional Chinese medicinal materials promotes the inheritance and innovation of traditional Chinese medicine,and contributes to rural revitalization and the building of an agricultural power.This article provides an overview of the traditional Chinese medicinal materials in Hubei Province.It conducts a detailed investigation into the intellectual property resources of the province s traditional Chinese medicinal materials from aspects such as traditional knowledge,genetic resources,new plant varieties,patents,geographical indications,and trademarks.It analyzes the eight main problems in the protection,inheritance,and innovative development of intellectual property rights,and puts forward corresponding suggestions,such as establishing an intellectual property rights rule system for specific fields of traditional Chinese medicinal materials,promoting the"Famous Brand Action in Rural Areas",and building a"Hubei s Sixteen Superior Herbs"cluster of traditional Chinese medicinal materials.
